As a result of autoimmunity to self-antigens, approximately 60%–80% of patients with HT have serum antibodies against thyroglobulin (Tg) and 90%–95% have antibodies against thyroid peroxidase (TPO) (91, 92). Here, TG is linked to hematocrit.